ADLINE CHEM LAB LIMITED Share Price

BSE: 524604

S Cap

₹ 13.02

-₹0.68 (-4.96%)

Last updated 14 Aug, 2026, 12:32 IST

ADLINE CHEM LAB LIMITED Share Price Today

As of 14 Aug 2026, ADLINE CHEM LAB LIMITED share price is ₹13.02. The stock opened at ₹13.02, compared to its previous close of ₹13.70. During today's trading session, ADLINE CHEM LAB LIMITED share price moved in the range of ₹13.02 to ₹13.02, with an average price of ₹13.02 for the day. Looking at its last 52-week, the stock has touched a low of ₹7.60 and a high of ₹17.95.

₹13.02

4.96% down today

₹13.02

1D LOW

1D HIGH

Stock Performance

OutperformingBeat Nifty by 7.04 % in last 3 month

ADLINE CHEM LAB LIMITED Returns Calculator

If you would've invested

₹

₹1,000₹1Cr

Historical Returns

1 Year

₹4,39,271-₹60,729 (-12.15%)

3 Year

₹4,90,580-₹9,420 (-1.88%)

5 Year

₹12,25,989+₹7,25,989 (+145.20%)

₹13.02₹14.38

Circuit Low

Circuit High

₹7.60₹17.95

52-Week Low

52-Week High

Circuit

₹13.02

₹14.38

52-week

₹7.60

₹17.95

About ADLINE CHEM LAB LIMITED

ISIN

INE276T01018

Sector Market Cap

₹ 8.01 Cr

Adline Chem Lab Limited is an India-based company. The Company is engaged in the business of marketing pharmaceutical products. The Company operates in one segment: pharmaceutical products. The Company's products for the domestic market include anti-infectives, bone health, gastroenterology care, hemostatic, multi-vitamins, pediatric care, pain and inflammation, pregnancy and reproductive care, respiratory care and hepatocare. Its products for the international market include tablets, capsules and injections. Its veterinary products include B Complex Liver Extract with Vitamin B12 Inection, Chlorpheniramine Injection IP, Triflupromazine Hydrochloride Injection IP, Triamcinolone Acctonide Injection IP, Triamcinolone Acetonide IP and Tetracyclin-bolus Tablets. It also offers educational supplements. It offers manufacturing facilities for tablets, capsules, liquid orals and small volume parentals for contract manufacturing.

ADLINE CHEM LAB LIMITED Financial Highlights

Revenue: ADLINE CHEM LAB LIMITED reported revenue of ₹0.01 crore in FY26 vs ₹0.25 crore in FY25. It showed a decrease of 96.00% on a yearly basis.
Operating Profit: ADLINE CHEM LAB LIMITED reported an operating loss of ₹0.32 crore in FY26 vs ₹0.21 crore in FY25. It showed a decrease of 52.38% on a year-on-year basis.
Net Profit: ADLINE CHEM LAB LIMITED reported a net loss of ₹0.28 crore in FY26 vs ₹0.13 crore in FY25. It showed a decrease of 115.38% on a yearly basis.

ADLINE CHEM LAB LIMITED Quarterly Result Highlights

ADLINE CHEM LAB LIMITED reported revenue of ₹0.01 crore in Mar 2026, compared with ₹0.00 crore in Dec 2025.
ADLINE CHEM LAB LIMITED reported an operating loss of ₹0.11 crore in Mar 2026, compared with ₹0.07 crore in Dec 2025, representing a decrease of 57.14% on a quarter-on-quarter (QoQ) basis.
ADLINE CHEM LAB LIMITED reported a loss of ₹0.09 crore in Mar 2026, compared with ₹0.06 crore in Dec 2025, reflecting a decrease of 50.00% on a QoQ basis.
The earnings per share (EPS) of ADLINE CHEM LAB LIMITED stood at ₹0.21 during Mar 2026.

Know more

Promoters

25.85%

FII

0.00%

Other DII

0.00%

Retail and other

74.15%

Mutual funds

0.00%

Foreign institutions - FII

FII shareholding by period
Sep 2025	0.00%
Dec 2025	0.00%
Mar 2026	0.00%
Jun 2026	0.00%

Mkt Cap Cr

8.01

P/E

-28.54

P/B

0.00

ROE

15.84%

D/E

-1.02

ROCE

-495.76%

Div. Yield

0.00%

EPS(TTM)

-0.48

Turnover

0.00

EV/EBITDA

-57.34

Net Margin

0.00%

Op. Margin

0.00%

ROA

-385.71%

Quick Ratio

0.00

Curr. Ratio

3.97

Mkt Cap Cr

8.01

P/E

-28.54

P/B

0.00

ROE

15.84%

D/E

-1.02

ROCE

-495.76%

Div. Yield

0.00%

EPS(TTM)

-0.48

Turnover

0.00

EV/EBITDA

-57.34

Net Margin

0.00%

Op. Margin

0.00%

ROA

-385.71%

Quick Ratio

0.00

Curr. Ratio

3.97

Based on fundamentals, this stock's

Performance

Very Poor

Adline Chem Lab has not beaten FD return of 7%

Valuation

Overvalued

Adline Chem Lab appears overvalued compared to its peers

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROE	D/E	ROCE	Book Value	Div. Yield	Turnover	EPS(TTM)
Sun Pharmaceutical Industries	4,66,155.00	38.47	5.58	13.74%	0.61	17.33%	93.24	0.82%	0.48	10.90
Divis Laboratories	2,25,648.00	77.15	13.46	15.32%	0.00	19.56%	629.49	0.35%	0.55	98.19
Torrent Pharmaceuticals	1,85,479.00	86.03	22.06	25.49%	1.69	13.85%	222.76	0.69%	0.49	58.70
Zydus Lifesciences	1,17,007.00	25.48	4.32	18.59%	0.31	17.35%	237.30	0.09%	0.33	35.38
Cipla	1,18,027.00	35.17	3.43	11.27%	0.00	14.95%	423.36	0.89%	0.45	43.52
Lupin	1,03,380.00	18.62	4.61	23.76%	0.04	24.88%	659.05	0.80%	0.57	129.18
Mankind Pharma	99,862.40	48.30	6.13	11.74%	0.34	13.13%	397.02	0.04%	0.44	49.37
Dr. Reddy's Laboratories	1,00,662.00	31.62	2.64	11.07%	0.18	12.54%	377.96	0.66%	0.41	38.68
Laurus Labs	99,474.20	91.23	18.77	16.77%	0.40	16.14%	97.20	0.11%	0.67	13.72
Aurobindo Pharma	96,215.60	25.93	2.54	9.25%	0.19	11.76%	391.14	0.24%	0.38	41.58

ADLINE CHEM LAB LIMITED Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Revenue	₹0.00	₹0.00	₹0.00	₹0.74
Other Income	₹0.25	₹0.00	₹1.00	₹0.18
Total Revenue	₹0.25	₹0.00	₹1.00	₹0.92
Total Expenses	₹0.45	₹0.30	₹0.88	₹1.39
Profit Before Tax	-₹0.21	-₹0.30	-₹4.23	₹0.67
Tax	-₹0.07	-₹0.03	₹0.00	-₹0.05
Profit After Tax	-₹0.13	-₹0.27	-₹4.23	₹0.72
EPS - Basic	-₹0.21	-₹0.46	-₹7.24	₹1.23
EPS - Diluted	-₹0.21	-₹0.46	-₹7.24	₹1.23

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Profit before tax	-₹0.21	-₹0.30	-₹4.23	₹0.72
Income before WC changes	-₹0.31	-₹0.18	₹0.22	-₹0.11
Change in Assets	-₹0.01	₹0.00	₹0.40	₹1.75
Change in Liabilities	-₹0.01	₹0.01	-₹0.60	-₹1.43
Change in WC	-₹0.02	₹0.01	-₹0.20	₹0.32
Cash flow from Operations	-₹0.23	-₹0.17	₹0.01	₹0.21
Cash flow from Investing	₹0.00	₹0.00	₹0.00	₹0.00
Cash flow from Financing	₹0.25	₹0.15	₹0.00	-₹0.01
Total Cash Flow	₹0.02	-₹0.02	₹0.01	₹0.20
Cash (Start of the year)	₹0.04	₹0.06	₹0.05	-₹0.16
Cash (End of the year)	₹0.06	₹0.04	₹0.06	₹0.05

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Non-Current Assets	₹0.01	₹0.00	₹0.00	₹4.44
Current Assets	₹0.07	₹0.04	₹0.06	₹0.43
Total Assets	₹0.08	₹0.04	₹0.06	₹4.87
Current Liabilities	₹0.02	₹1.38	₹1.34	₹1.93
Net Current Asset	₹0.05	-₹1.34	-₹1.28	-₹1.49
Non-Current Liabilities	₹1.55	₹0.03	₹0.29	₹0.30
Equity Capital	-₹1.49	-₹1.37	-₹1.57	₹2.65
Total Equity & Liabilities	₹0.08	₹0.04	₹0.06	₹4.87